Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?
Andrew J LasterGordon K LamHeather S GladueAhmad A KashifErin P SiceloffVirginia D LackeyCheryl R RobertsonAshley L TociLeonard H CalabresePublished in: RMD open (2022)